Investigational Site Number 8022 is a clinical research site located in Kansas City, Missouri, United States 64108.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Investigational Site Number 8022 has participated in 1 clinical trials.
Therapeutic areas: Hyperphosphatemia, Chronic Kidney Disease.
Sponsors: Genzyme, a Sanofi Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Missouri · View every site in Kansas City
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigational Site Number 8022 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigational Site Number 8022 has 1 clinical trials on record. Their work covers Hyperphosphatemia, Chronic Kidney Disease.
Investigational Site Number 8022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.